Document is current
Any future updates will be listed below
-
Authors
Pierson Smela, Merrick
Kramme, Christian C https://orcid.org/0000-0002-7518-8111
Fortuna, Patrick R J
Wolf, Bennett
Goel, Shrey
Adams, Jessica
Ma, Carl https://orcid.org/0000-0002-1016-9278
Velychko, Sergiy https://orcid.org/0000-0002-6227-3966
Widocki, Ursula https://orcid.org/0009-0002-0886-9045
Srikar Kavirayuni, Venkata
Chen, Tianlai
Vincoff, Sophia
Dong, Edward
Kohman, Richie E https://orcid.org/0000-0002-7412-671X
Kobayashi, Mutsumi https://orcid.org/0000-0001-7897-2633
Shioda, Toshi https://orcid.org/0000-0002-9434-7835
Church, George M
Chatterjee, Pranam
-
Funding
Funding for this research was provided by:
Synthetic Biology Platform Wyss Institute
Sponsored Research Agreement Gameto Inc and Colossal Inc
NICHD F31 (F31HD108898-01A1)
Duke University (Institutional Start Up Funds)
- License Information
-
More Information
Article History
Received: 2 May 2024
Revised: 18 December 2024
Accepted: 8 January 2025
First Online: 23 January 2025
Disclosure and competing interests statement
: PC, CCK, MPS, and GC are listed as inventors for the International Patent Application No.: PCT/US2023/065143, entitled: “Methods and Compositions for Producing Primordial Germ Cell-Like Cells,” and International Patent Application No.: PCT/US2023/065145, entitled: “Methods and Compositions for Producing Oogonia-Like Cells.” PRJF declares paid consultancy for Gameto Inc. CCK is currently the Chief Scientific Officer of Gameto, Inc. MPS is currently the Chief Scientific Officer of Ovelle Inc. GMC serves on the scientific advisory board of Gameto, Inc., Colossal Biosciences, and GCTx. PC is a co-founder, scientific advisor to Gameto, Inc.
